CIK 0001478320 · Large accelerated filer
Adaptive Biotechnologies Corp
Sign in to watch- Ticker
- ADPT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- operating
- EIN
- 270907024
- Phone
- 206-659-0067
- Business address
- 1165 EASTLAKE AVE E, SEATTLE, WA, 98109
- Former names
- Adaptive TCR Corp
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Executive or director change
- 8-K Event Delisting notice
- 4 Planned sale Chief Financial Officer sold 134,961 shares at $8.14 ($1,098,583)
- 144 Insider Sale of Securities
- 4 Planned sale Chief Financial Officer sold 70,000 shares at $8.53 ($597,100)
- 144 Insider Sale of Securities
- 8-K Event Executive or director change · Shareholder vote results
- 4 Open-market sale Chief Financial Officer sold 38,000 shares at $7.16 ($272,080)
- DEFA14A Proxy Proxy Materials
- 8-K Event Regulation FD disclosure · Other events
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Planned sale Chief Operating Officer sold 3,125 shares at an average $8.60 ($26,863)
- 8-K Event Executive or director change
- 4 Open-market sale Director sold 2,341 shares at $8.49 ($19,878)
- 4 Grant or award Director acquired 14,775 shares (grant or award)
Page 16 of 42 · 836 filings